Enoxaparin sodium and Hypernatraemia - a phase IV clinical study of FDA data

Summary:

Hypernatraemia is reported as a side effect among people who take Enoxaparin sodium (enoxaparin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Senna, and have Cardiac failure.

The phase IV clinical study analyzes which people have Hypernatraemia when taking Enoxaparin sodium. It is created by eHealthMe based on reports of 24,091 people who have side effects when taking Enoxaparin sodium from the FDA, and is updated regularly.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.

What is Hypernatraemia?

Hypernatraemia (an abnormally high plasma concentration of sodium ions) is found to be associated with 644 drugs and 807 conditions by eHealthMe. Check the latest studies of Hypernatraemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

24,091 people reported to have side effects when taking Enoxaparin sodium.
Among them, 18 people (0.07%) have Hypernatraemia.

Could Enoxaparin sodium cause Hypernatraemia?

Among these 18 people:

How long have people been on Enoxaparin sodium when they have Hypernatraemia? *

What is the gender of people who have Hypernatraemia when taking Enoxaparin sodium? *

female: 75 %
male: 25 %

What is the age of people who have Hypernatraemia when taking Enoxaparin sodium? *

What are other drugs people take besides Enoxaparin sodium? *

What are other side effects people have besides Hypernatraemia? *

Dehydration (dryness resulting from the removal of water): 7 people, 38.89%
Hypokalemia (low potassium): 4 people, 22.22%
Diabetes Insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 4 people, 22.22%
High Blood Pressure: 2 people, 11.11%
Weight Decreased: 2 people, 11.11%
Torsade De Pointes (a abnormal heart rate with abnormal beating pattern): 2 people, 11.11%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 11.11%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 11.11%
Drowsiness: 2 people, 11.11%
Metabolic Alkalosis (too much bicarbonate in the blood): 2 people, 11.11%

What are the existing conditions these people have? *

Cardiac Failure: 2 people, 11.11%
Renal Cell Carcinoma (a kidney cancer): 1 person, 5.56%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 5.56%
Peritoneal Abscess: 1 person, 5.56%
Nephropathy (damage to or disease of a kidney): 1 person, 5.56%
Femoral Neck Fracture (neck of femur bone fracture): 1 person, 5.56%
Diabetes: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Enoxaparin sodium and have Hypernatraemia?

- Check whether Hypernatraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enoxaparin sodium:

Enoxaparin sodium (24,181 reports)

Hypernatraemia treatments and more:

Hypernatraemia (6,339 reports)

Browse all side effects of Enoxaparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypernatraemia:

Hypernatraemia (644 drugs)

Browse all the conditions that are associated with Hypernatraemia:

Hypernatraemia (807 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Enoxaparin sodium) and Enoxaparin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.